Multiple Molecular Dynamics Simulations of the Inhibitor GRL-02031 Complex with Wild Type and Mutant HIV-1 Protease Reveal the Binding and Drug-Resistance Mechanism

Human immunodeficiency virus type 1 (HIV-1) protease is regarded as a fascinating target for drug development against HIV infection. However, mutations causing drug resistance severely limit the efficiency of the recently marketed drugs in the treatment of HIV replication. To elucidate the binding m...

Description complète

Détails bibliographiques
Publié dans:Langmuir : the ACS journal of surfaces and colloids. - 1985. - 36(2020), 46 vom: 24. Nov., Seite 13817-13832
Auteur principal: Wang, Ruige (Auteur)
Autres auteurs: Zheng, Qingchuan
Format: Article en ligne
Langue:English
Publié: 2020
Accès à la collection:Langmuir : the ACS journal of surfaces and colloids
Sujets:Journal Article Carbamates GRL 02031 HIV Protease Inhibitors Pharmaceutical Preparations Sulfonamides Peptide Hydrolases EC 3.4.- HIV Protease EC 3.4.23.- p16 protease, Human immunodeficiency virus 1